Endocrine/Adrenal Cancer

ARUP offers molecular testing for multiple endocrine neoplasia (MEN) syndromes which are characterized by tumors involving multiple endocrine glands. Testing includes sequencing and deletion/duplication studies of the MEN1 gene, RET sequencing and specific RET mutation testing.  Additionally, the ARUP Scientific Resource for Research and Education hosts the MEN1 and MEN2 (RET) databases, which serve to record all MEN1 and RET sequence changes relevant to the multiple endocrine neoplasis syndromes, as well as any associated clinical information and pertinent literature references.
Test # Test Name Test Keywords Additional Information
0080650 17-Ketosteroids, Urine Endocrine/Adrenal Cancer
2003427 Adrenocorticotropic Hormone (ACTH) by Immunohistochemistry Acromegaly, Cushing Syndrome, Hypopituitarism, Tumor Markers, Endocrine/Adrenal Cancer, Lung Cancer, Pituitary Cancer, thymoma, medullary thyroid carcinoma Stain and return service only
0070010 Adrenocorticotropic Hormone, Plasma Endocrine/Adrenal Cancer, Lung Cancer, Pituitary Cancer, thymoma, medullary thyroid carcinoma
2003481 Calcitonin by Immunohistochemistry Medullary Thyroid Cancer, Tumor Markers, Endocrine/Adrenal Cancer, Head and Neck Cancer, Thyroid medullary carcinomas Stain and return service only
0070006 Calcitonin, Serum or Plasma Endocrine/Adrenal Cancer, Head and Neck Cancer, MEN
2003830 Chromogranin A by Immunohistochemistry Neuroendocrine Tumors (NET), Carcinoid Tumors, Medullary Thyroid Cancer, Tumor Markers, Paraganglioma, Carotid body tumor, Olfactory neuroblastoma, pituitary adenomas, islet cell tumors, phaeochromocytomas, medullary thyroid carcinomas, Merkel cell tumors, and carcinoids Stain and return service only
0080469 Chromogranin A, Serum Endocrine/Adrenal Cancer, General Oncology, Gastrointestinal Cancer, Lung Cancer, Neuroendocrine Cancer, MEN, NET
2010229 Cytogenomic Molecular Inversion Probe Array, Copy Number and Heterozygosity Assessment - Formalin-Fixed Paraffin-Embedded (FFPE) Tissue FFPE ARRAY, array CGH; aCGH; Array Comparative Genomic Hybridization; Chromosomal Microarray; CMA;  CGH; Microarray; Single-nucleotide-polymorphism (SNP) array; Whole Genome Array; tumor; oncology, formalin-fixed, paraffin-embedded, FFPE; tissue
0070040 Dehydroepiandrosterone Sulfate, Serum or Plasma Endocrine/Adrenal Cancer
0070075 Gastrin, Serum Gastrinoma, Pancreatic Neuroendocrine Tumors (NET), Carcinoid Tumors, Tumor Markers, Endocrine/Adrenal Cancer, Gastrinoma, Carcinod Tumors, MEN, NET, Neuroendocrine, tumor markers
0099165 Glucagon, Plasma Gastrointestinal Cancer, Neuroendocrine Cancer, Neuroendocrine Tumor, Neuroendocrine Neoplasm, Carcinoid Tumor
2012032 Hereditary Cancer Panel, Sequencing and Deletion/Duplication CANCERPAN, Lynch syndrome, breast cancer, multiple endocrine neoplasia, melanoma, retinoblastoma, paraganglioma, Li-Fraumeni, familial adenomatous polyposis, Peutz-Jegher, HNPCC, inherited cancer, renal cancer, GI cancer, colorectal cancer, NGS cancer panel
2007108 Hereditary Paraganglioma-Pheochromocytoma (SDHB) Sequencing and Deletion/Duplication Additional Technical Information
2007167 Hereditary Paraganglioma-Pheochromocytoma (SDHB, SDHC, and SDHD) Sequencing and Deletion/Duplication Panel
2007117 Hereditary Paraganglioma-Pheochromocytoma (SDHC) Sequencing and Deletion/Duplication Additional Technical Information
2007122 Hereditary Paraganglioma-Pheochromocytoma (SDHD) Sequencing and Deletion/Duplication Additional Technical Information
0050184 Metanephrines, Plasma (Free) Endocrine/Adrenal Cancer
2005359 Multiple Endocrine Neoplasia Type 1 (MEN1) Sequencing MEN1 FGS, Multiple endocrine adenomatosis, Wermer syndrome, Multiple Endocrine Neoplasias (MEN)
2005360 Multiple Endocrine Neoplasia Type 1 (MEN1) Sequencing and Deletion/Duplication MEN1 FGA, Multiple endocrine adenomatosis, Wermer syndrome, Multiple Endocrine Neoplasias (MEN)
0051390 Multiple Endocrine Neoplasia Type 2 (MEN2), RET Gene Mutations by Sequencing MEN2 SEQ, Thyroid Cancer, Pheochromocytoma, Multiple Endocrine Neoplasias (MEN), MEN 2A, MEN 2B, familial medullary thyroid carcinoma, FMTC, RET proto-oncogene
2004052 Neuron Specific Enolase, Polyclonal (NSE P) by Immunohistochemistry Neuroendocrine Marker, neuronal or neuroendocrine cells and their tumors: neuroblastomas and retinoblastomas Stain and return service only
2004118 Parathyroid Hormone (PTH) by Immunohistochemistry Acromegaly, Parathyroid Cancer, Tumor Markers, adenomas and primary and secondary hyperplasias Stain and return service only
0070172 Parathyroid Hormone, Intact with Calcium Hypocalcemia, Hypercalcemia, Multiple Endocrine Neoplasias (MEN), Tumor Markers
0070346 Parathyroid Hormone, Intact, Serum or Plasma Bone Cancer, Endocrine/Adrenal Cancer, Head and Neck Cancer
0070256 Proinsulin/Insulin Ratio Insulinoma, Tumor Markers
0070115 Prolactin, Serum or Plasma Endocrine/Adrenal Cancer, Pituitary Cancer
2004091 Protein Gene Product (PGP) 9.5 by Immunohistochemistry Glucagonoma, Somatostatinoma, VIPoma, Ewing Sarcoma, Gastrinoma, Pancreatic Neuroendocrine Tumors (NET), Carcinoid Tumors, Pancreatic Cancer, Pheochromocytoma, Tumor Markers, neuronal neoplasis Stain and return service only
2006948 SDHB with Interpretation by Immunohistochemistry
0081058 Testosterone, Females or Children Endocrine/Adrenal Cancer, Gynecologic Cancer
0050105 Thyroglobulin Antibody Thyroiditis, Thyroid Disease, Tumor Markers
2004145 Thyroglobulin by Immunohistochemistry Thyroid Cancer, Tumor Markers, Thyroid Disease Stain and return service only
2006550 Thyroglobulin by LC-MS/MS, Serum or Plasma Endocrine/Adrenal Cancer, Head and Neck Cancer
0020753 Thyroglobulin, Fine Needle Aspiration (FNA) Thyroid Cancer, Tumor Markers